An early, novel arginine methylation of KCa3.1 attenuates subsequent T cell exhaustion.
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Cd8-positive
SUBMITTER: 
Suresh Poudel
LAB HEAD: Douglas R. Green
PROVIDER: PXD064423 | Pride | 2025-05-29
REPOSITORIES: Pride
Dataset's files
Items per page: 5 1 - 5 of 53 |
Similar Datasets
Project description:Citrullinated and unmodified peptides (>95% purity, ProImmune AB) were immobilized onto a chemically modified glass slide, sera from RA patients and healthy controls were applied into the reactions sites and fluorescence intensity after incubation with anti-human IgG antibody was acquired in a laser scanner. Final results for each citrullinated peptide were calculated by subtracting the intensity values of corresponding arginine containing control peptide from citrullinated peptide for all RA patients and controls.
2015-10-25 | E-MTAB-3606 | biostudies-arrayexpress
Project description:MicroRNA (miRNA) dysregulation is well-documented in psychiatric disease, but miRNA dynamics during adolescent and early adult brain maturation, when symptoms first appear for many of these diseases, remain poorly understood. Here, we use RNA sequencing to examine miRNAs and their mRNA targets in cortex and hippocampus from early, mid-, and late adolescent and adult mice. We also use Quantitative Proteomics by tandem mass tag mass spectrometry (TMT-MS) to examine protein dynamics in cortex from the same subjects.
2023-02-17 | PXD040229 | Pride
Project description:PRMT5 is the major enzyme that catalyzes the symmetric dimethylation of arginine (sDMA) in mammalian cells. Its activity is crucial for many biological processes including transcriptional regulation, mRNA processing, as well as DNA damage and repair. However, the protein substrates identified for PRMT5 have yet been limited in numbers, hindering the understanding of PRMT5 functions in normal as well as diseased cells. Herein we developed an optimized strategy for proteomic profiling of cellular sDMA and apply it to the discovery of novel PRMT5 substrates. Our results show that a combination of proteolytic digestion by the metalloprotease ulilysin and using electron-transfer dissociation with supplemental activation as the mass spectrometry method significantly increased sDMA site identification and localization after immuno-affinity enrichment. By employing SILAC-based differential quantitative proteomic approach and a PRMT5 specific inhibitor, we identified 325 sDMA sites being regulated by PRMT5, 220 being novel sites, which greatly expanded the number of PRMT5 substrates. Biochemical studies confirmed the newly discovered PRMT5 substrate, Plasminogen activator inhibitor 1 RNA-binding protein (SERBP1) and revealed that the RGG/RG motif in the central region of SERBP1 contains both PRMT5-catalyzed sDMA and Type I PRMT-catalyzed asymmetric dimethylation of arginine (aDMA). Unexpectedly, using the optimized methylarginine profiling strategy, we also discovered arginine trimethylation, a previously unknown type of modification, on the central RGG/RG region of SERBP1. By mutational studies we demonstrated that the trimethyl modification on R172 of SERBP1 regulates its recruitment to stress granule (SG) under oxidative stress, indicating a functional role of arginine trimethylation in the cell. Overall, the optimized profiling strategy not only enabled the identification of extensive, non-overlapping sDMA sites and novel PRMT5 substrates, but also revealed a potentially important new PTM, arginine trimethylation. The work lays the foundation for further investigations on the functional interplay of different methylation modifications on arginines, especially in the heavily methylated RGG/RG motif of many RNA-binding proteins.
2024-04-30 | PXD037425 | Pride
Project description:High-throughput identification of arginine methylation using clinical samples has not previously been studied.
2020-08-05 | PXD011765 | Pride
Project description:Protein methylation, especially in arginine and lysine, is one of most important post-translational modifications (PTMs). In this project, we developed a novel chemical strategy which enabled almost complete depletion of histidine-conatining peptides in protein digestion and thereby resulted in the identification of more low-abundance arginine/lysine methylpeptides.
2021-03-08 | PXD023845 | Pride
Project description:T cell receptor (TCR) activation is regulated in multifaceted ways, including niche-specific nutrient availability. We investigated how methionine (Met) availability and TCR signaling interplay in the earliest events of T cell activation to affect subsequent cell fate. Limiting Met during the initial 30 minutes of TCR engagement increased Ca2+ influx, NFAT1 (Nfatc2) activation and promoter occupancy leading to T cell exhaustion. We identified changes in the protein arginine methylome during the initial TCR engagement and discovered a novel arginine methylation of a Ca2+-activated potassium transporter, KCa3.1, which regulates Ca2+-mediated NFAT1 signaling for optimal activation. Ablation of KCa3.1 arginine methylation increased NFAT1 nuclear localization, rendering T cells dysfunctional in murine tumour and infection models. Furthermore, acute Met supplementation at early stages reduced nuclear NFAT1 in tumour-infiltrating T cells and augmented their anti-tumour activity. Our findings identify a metabolic event occurring early after T cell activation that influences cell fate.
2025-05-29 | GSE221350 | GEO
Project description:The formation of condensates in membraneless organelles is thought to be driven by protein phase separation. Arginine methylation and serine/threonine phosphorylation are important in the phase separation process, however these post-translational modifications are often present in intrinsically disordered regions that are difficult to analyse with standard proteomic techniques. Here we use a multi-protease and multi-MS/MS fragmentation approach, coupled with heavy methyl SILAC and phospho- or methyl-peptide enrichment, for the analysis of arginine methylation and serine/threonine phosphorylation, and to understand their co-occurrence in condensate-associated proteins. For Saccharomyces cerevisiae, we report a 50% increase in the known arginine methylproteome, involving 15 proteins that are almost all condensate-associated. Importantly, some of these proteins have arginine methylation on all predicted sites – providing evidence that this modification can be pervasive. We explored whether arginine methylated condensate-associated proteins are also phosphorylated, and found 12 such proteins to carry phosphoserine or phosphothreonine. In Npl3, Ded1 and Ssbp1, single peptides were found to carry both modifications, indicating a co-occurrence in close proximity and on the same protein molecule. We show that these co-modifications occur in regions of disorder and that arginine methylation is typically on basic regions of disorder. For phosphorylation, its association with charged regions of condensate-associated proteins was less consistent, although some regions with multisite phosphorylation sites were strongly acidic. We conclude that arginine-methylated proteins associated with condensates are typically co-modified with protein phosphorylation.
2021-09-17 | PXD022403 | Pride
Project description:Arginine methylation is a ubiquitous post-translational modification involved in many biological processes such as transcription, cell signaling and RNA splicing. Tudor domains by far are the major effector domain family for arginine methylation mark recognition. Here we characterize SART3 as a novel selective reader for symmetric dimethylarginine (Rme2s) marks. SART3 harbors a series of HAT (Half-a-TPR) repeats that are aromatic-rich, and it is this region that binds Rme2s motifs. An analysis of the reported structure of the HAT repeats of SART3 identified a putative aromatic cage that potentially “read” the Rme2s-modified motifs, and the key aromatic residues required for Rme2s recognition were identified. We further confirm that this Rme2s reader ability is important for SART3-mediated RNA splicing. Together, our studies revealed that the evolutionarily conserved SART3 HAT domain was a novel reader of Rme2s mark involved in RNA splicing.
2024-10-17 | PXD046708 | Pride
Project description:The conserved box H/ACA RNPs consist of one box H/ACA RNA and 4 core proteins: Dyskerin, NHP2, NOP10 and GAR1. The assembly of the H/ACA RNPs is a stepwise process which requires several assembly factors: SHQ1, NAF1, the Survival of Motor Neuron complex SMN, and the R2TP complex. It implicates the co-transcriptional assembly of a pre-particle containing the nascent RNAs, Dyskerin, NOP10, NHP2 and NAF1. The latest keeps the H/ACA RNP inactive, and needs to be replaced by GAR1 to produce mature and functional H/ACA RNPs in the Cajal bodies. In this study, we explore in details the molecular mechanism leading to the assembly of mature box H/ACA RNPs. We performed extensive analysis of GAR1, NHP21 and NAF interactomes by quantitative stable isotope labeling by amino acids in cell culture proteomic analyses (SILAC), and revealed new assembly intermediates: 1) an early protein-only pre-H/ACA RNP complex containing the core proteins DKC1, NOP10 and NHP2, and the assembly factors SHQ1 and NAF1, and 2) a late assembly intermediates containing the RNA, the core proteins and NAF1. We showed that the SMN complex is associated with late forming H/ACA pre-RNP complexes containing GAR1. Moreover, our study identifies new proteins highly and specifically associated with GAR1, NHP2 and NAF1, reflecting their importance in box H/ACA assembly or function, such as the PRMT1 and PRMT5 arginine methylases. MS analysis of purified GAR1 revealed new sites of arginine methylations in the two GAR domains of GAR1, and showed that most of these methylated arginines exist both in mono-methylated and di-methylated forms in cells. By different methods, we showed that unmethylated GAR1 is correctly incorporated in H/ACA RNPs. Therefore, GAR1 methylation should be important for its function.
2023-05-10 | PXD026752 | Pride
Project description:The overall goal of this study was to identify methylated arginine residues on the Trypanosoma brucei RNA binding protein, ZFP3, and determine their functions in transcriptome regulation. We expressed Ty-tagged ZFP3 in procyclic form T. brucei, immunoprecipitated triplicate samples with anti-Ty antibodies, and subjected these samples to mass spectrometry to identify posttranslational modifications. We identified a highly methylated RGG domain, abundant R methylation at R109 in an unexpected context, and abundant tyrosine phosphorylation at Y4. To identify which protein arginine methyltransferases catalyzed these R methylation events, we performed in vitro methylation assays with TbPRMT1, TbPRMT6, and TbPRMT7 along with wild type and mutant ZFP3 substrates. These experiments showed that TbPRMT1 and TbPRMT7 methylate the RGG domain, while TbPRMT6 modifies R109. To ask how R methylations within affect ZFP3 transcriptome regulation, we overexpressed WT-ZFP3-Ty, R68,71K-ZFP3-Ty (hypomethylated) or R68,71F-ZFP3-Ty (methylmimic) in procyclic T. brucei. Overerexpression of WT-ZFP3-Ty lead to an increased expression of 749 tranascripts and decreased expression of 169 transcripts (1.5-fold change; padj<0.05). Overexpression of hypomethylated or methylmimic ZFP3 nearly abolished the capacity of ZFP3 to regulate three transcriptome, leading to changes in the abundances of less than 10 transcripts in either cell line. From these data, we conclude that arginine residues in the ZFP3 RGG domain are critical for its gene regulatory function.
2021-05-25 | PXD025153 | Pride